Compound ID | 613
Class: Macrolide
| Agent Type: | Semisynthetic; Small molecule; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Unknown |
| Target Pathogen: | Active against macrolide-resistant Streptococcus pneumoniae |
| Description: | Semisynthetic compound; a C-4"-carbamate macrolide derivative; Girard D, Mathieu HW, Girard AE, et al. In vivo oral efficicacy of CP-544372, a new erthromycylamine C4 carbamate, against macrolide-resistant Pneumococci and Haemophilus influenzae. 38th-Intersci-Conf-Antimicrobial-Agents-Chemother 1998; 263. |
| Institute where first reported: | Pfizer, USA |
| Year first mentioned: | 1998 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://www.nature.com/articles/ja201044.pdf |